Hansoh Pharmaceutical Group Company Limited
3692
Hisse Senetlerindeki Sıralama
#970
Hansoh Pharmaceutical Group Company Limited, an investment holding company,... Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Mailingda, Hengsen, Oulanning, Ailanning, and Ameining; XINYUE; and Saint Luolai, Fulaimei, Ruibote, Fulaidi, Fulairui, Punuoan tablets, etc. It has licence agreements with GlaxoSmithKline Intellectual Property (No.4) Limited to develop, manufacture, and commercialize HS-20089 and HS-20093 for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy; Biotheus Inc. to develop, produce, and commercialize bispecific antibody-drug conjugate product; and with Merck Sharp & Dohme LLC (MSD) to develop, manufacture, and commercialize HS-10535, an investigational pre-clinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist. The company was founded in 1995 and is headquartered in Shanghai, China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.
Hisse Fiyatı
$4.06
Son senkronizasyon: 2026-10-16
Piyasa Değeri
$24.62B
Değişim (1 gün)
1.15%
Değişim (1 yıl)
-13.40%
Ülke
CN
Ticaret Hansoh Pharmaceutical Group Company Limited (3692)
Kategori
Healthcare
Hansoh Pharmaceutical Group Company Limited (3692) için EPS
June 2026 itibariyle EPS TTM: $0.16
Hansoh Pharmaceutical Group Company Limited şirketinin en son finansal raporlarına ve hisse senedi fiyatına göre, şirketin mevcut EPS'si (TTM) $0.16'dir. 2023 yılı sonunda, şirketin EPS'si $0.07 idi; bu, 2022 yılındaki EPS olan $0.06 ile önceki yıla göre artış.
Hansoh Pharmaceutical Group Company Limited için 2016 - 2026 arasındaki EPS geçmişi
Her yıl sonunda EPS
| Yıl | EPS | Değiştir |
|---|---|---|
| 2026 (TTM) | $0.16 | 59.40% |
| 2024 | $0.10 | 43.63% |
| 2023 | $0.07 | 10.66% |
| 2022 | $0.06 | -11.88% |
| 2021 | $0.07 | 7.42% |
| 2020 | $0.07 | -0.15% |
| 2019 | $0.07 | 40.63% |
| 2018 | $0.05 | 11.63% |
| 2017 | $0.04 | 14.97% |
| 2016 | $0.04 | 0.00% |
Benzer şirketler veya rakipler için EPS
| Şirket | EPS | EPS Farkı | Ülke |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 249.00% |
IN
|
